Cargando…

Erratum: The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2018
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927136/ https://www.ncbi.nlm.nih.gov/pubmed/31854348 http://dx.doi.org/10.4103/2303-9027.244803

Ejemplares similares

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging
por: D’Onofrio, Mirko, et al.
Publicado: (2017)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: EUS oriented
por: Iordache, Sevastiţa, et al.
Publicado: (2017)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice?
por: Zerbi, Alessandro, et al.
Publicado: (2017)

Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
por: Sulciner, Megan L., et al.
Publicado: (2022)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma
por: Kim, Hye Jin, et al.
Publicado: (2019)

Erratum to “Assessment of solid components of borderline ovarian tumor and stage I carcinoma: added value of combined diffusion- and perfusion-weighted magnetic resonance imaging”
por: Kim, See Hyung
Publicado: (2020)

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum
por: Cui, Ming, et al.
Publicado: (2021)

Accuracy of various criteria for lymph node staging in ductal adenocarcinoma of the pancreatic head by computed tomography and magnetic resonance imaging
por: Loch, Florian N., et al.
Publicado: (2020)

The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
por: Sakaguchi, Tatsuma, et al.
Publicado: (2020)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Vernuccio, Federica, et al.
Publicado: (2021)

Erratum to: Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor
por: Romeo, Margarita, et al.
Publicado: (2016)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis: Erratum
Publicado: (2017)

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
por: Acuna-Villaorduna, Ana, et al.
Publicado: (2022)

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
por: Hu, Qiancheng, et al.
Publicado: (2019)

Erratum: Magnetic Resonance Imaging Features of Adenosis in the Breast
por: Gity, Masoumeh, et al.
Publicado: (2017)

Erratum to clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma
Publicado: (2022)

Erratum: The computed tomography based anatomy of the ossa cuneiformia
por: Claaßen, Leif, et al.
Publicado: (2021)

Differentiation between non-hypervascular pancreatic neuroendocrine tumour and pancreatic ductal adenocarcinoma on dynamic computed tomography and non-enhanced magnetic resonance imaging
por: Ohki, Kazuyoshi, et al.
Publicado: (2019)

The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma
por: Kawahara, Kenji, et al.
Publicado: (2022)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

ERRATUM: Uniform magnetization transfer in chemical exchange saturation transfer magnetic resonance imaging
por: Lee, Jae-Seung, et al.
Publicado: (2013)

Borderline-resectable pancreatic adenocarcinoma: Contour irregularity of the venous confluence in pre-operative computed tomography predicts histopathological infiltration
por: Kaissis, Georgios A., et al.
Publicado: (2019)

Structured Reporting of Computed Tomography and Magnetic Resonance in the Staging of Pancreatic Adenocarcinoma: A Delphi Consensus Proposal
por: Granata, Vincenza, et al.
Publicado: (2021)

Erratum: Fluro-deoxygenase-positron emission tomography/computed tomography in hard metal lung disease
Publicado: (2016)

ERRATUM: Solving Quantum Ground-State Problems with Nuclear Magnetic Resonance
por: Li, Zhaokai, et al.
Publicado: (2012)

Erratum: Magnetic Resonance Imaging for Adaptive Cobalt Tomotherapy: A Proposal
Publicado: (2018)

Erratum to prognostic analysis of pancreatic carcinoma with portal system invasion following curative resection
Publicado: (2022)

Erratum to: Osteosarcoma follow-up: chest X-ray or computed tomography?
por: Paioli, Anna, et al.
Publicado: (2017)

Erratum to: Validation of the Spanish version of the borderline symptom list, short form (BSL-23)
por: Soler, Joaquim, et al.
Publicado: (2016)

Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagnostic computed tomography
por: Li, Xiawei, et al.
Publicado: (2021)

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data
por: Giovinazzo, Francesco, et al.
Publicado: (2020)

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
Publicado: (2023)

Erratum: Utility of 18F choline photon emission tomography/computed tomography in the diagnosis of parathyroid adenoma
Publicado: (2016)

Real‐world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma
por: Grogan, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bdh286tjf7b9a95tic4kjd78p9